Las Vegas Sands Corporation has confirmed reports regarding the health of casino mogul Sheldon Adelson, that have surfaced across a plethora of media outlets.
The founder, chairman and chief executive officer of Las Vegas Sands Corporation was thought to be undergoing treatment as part of a cancer battle, with the organisation confirming that Adelson is taking medication for the treatment of non-Hodgkin lymphoma.
As reported by Associated Press the poor health was first brought up during a court case with a Hong Kong businessman earlier in the week, when reported by one of Adelson’s lawyers for the company.
In a media statement to clarify the health condition of Adelson, the Sands China’s board of directors said: “The board of directors of Sands China Ltd, has recently noted certain media reports in relation to the health condition of Mr Sheldon Gary Adelson, the chairman of the board, chief executive officer, executive director and chairman of the nomination committee of the company.
“Mr Adelson is still dealing with certain side effects from medication he is taking for the treatment of non-Hodgkin’s lymphoma. These side effects have restricted his availability to travel or keep regular office hours.
“They have not, however, prevented him from fulfilling his duties as chairman of the board, chief executive officer, executive director and chairman of the nomination committee of the company. The company anticipates that Mr Adelson will return to his regular schedule at the completion of his treatment.”
In an overview provided by the NHS, it is stressed that most cases of non-Hodgkin lymphoma are considered very treatable.
With it added that treatment and outlook “varies greatly, depending on the exact type, grade and extent of the lymphoma, and the person’s age.
“Low-grade tumours don’t necessarily require immediate medical treatment, but are harder to completely cure.
“High-grade lymphomas need to be treated straight away, but tend to respond much better to treatment and can often be cured.”
